FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula I or to their salts M-T-YA-NO2, M-T represents residue COX-2 of inhibitor, in which T=-SO2NH-, -SO2NR-, -O-, -N(SO2R)-, where R - alkyl C1-C10; YA=-(B)b0-(C)c0 where b0=0 and c0=1, C represents two-valent radical -TC-Y-. Compounds can be used for treatment and/or prevention of inflammatory processes. Also described are: pharmaceutical compositions based on compounds I and application of compounds for production of medication.
EFFECT: increase of composition efficiency.
14 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NITROXY-DERIVATIVES AND THEIR SALTS, BASED ON THEM PHARMACEUTICAL COMPOSITION AND THEIR APPLICATION AS MEDICATIONS FOR CHRONIC PAIN TREATMENT | 2003 |
|
RU2340598C2 |
| MKK4 PROTEIN KINASE INHIBITORS FOR STIMULATION OF LIVER REGENERATION OR REDUCTION OR PREVENTION OF HEPATOCYTE DEATH | 2019 |
|
RU2788000C2 |
| FLUORINATED DERIVATIVES OF 4-AZASTEROID AS ANDROGEN RECEPTOR MODULATORS | 2003 |
|
RU2320670C2 |
| NOVEL HETEROARYLTRIAZOLE COMPOUNDS AS PESTICIDES | 2020 |
|
RU2824488C2 |
| HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS | 2020 |
|
RU2804033C2 |
| DERIVATIVES OF PYRAZOLINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2233272C2 |
| PHARMACEUTICAL COMPOSITION FOR USING IN THERAPY OF MALIGNANT NEOPLASM COMPRISING COMBINATION OF BISPHOSPHONATE, COX-2 INHIBITOR AND TAXOL | 2002 |
|
RU2317819C2 |
| QUINAZOLINE DERIVATIVES | 2005 |
|
RU2414468C2 |
| MONO-SODIUM SALT 5-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-7-[[2-HYDROXY-1-(HYDROXYMETHYL)-1-METHYETHYL]AMINO]-THIAZOLE[4,5-d]PYRIMIDINE-2(3H)-ON AS MODULATOR OF ACTIVENESS OF CHEMOKINE RECEPTORS, ITS APPLICATIONS AND PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2342389C2 |
| N-(2-BENZYL)-2-PHENYLBUTANAMIDES AS ANDROGEN RECEPTOR MODULATORS | 2005 |
|
RU2378255C2 |
